A study of analyst recommendations at the major brokerages shows that Travelers Companies Inc (TRV - Get Report) is the #28 broker pick, on average, out of the 30 stocks making up the Dow Jones Industrial Average, according to ETF Channel. Within the broader S&P 500, when components were ranked in terms of analyst favorites, TRV claims the #414 spot.In forming this rank, the analyst opinions from the major brokerage houses were tallied, and averaged; then, the underlying components were ranked according to those averages. Investors often interpret analyst opinions from different angles — when companies have a low rank among analysts, it isn't necessarily the case that investors should conclude that the stock will perform poorly. It can, of course, but a bullish investor could also take the contrarian angle and read into the data that there is lots of room for upside because the stock is so out of favor. For these reasons, we at ETF Channel find value to putting together these rankings, because both the top and the bottom ends of the list can often make for some interesting stock picking ideas for further research. Below is a chart of rank over time: According to the ETF Finder at ETF Channel, TRV makes up 4.75% of the iShares U.S. Insurance ETF (IAK) which is trading higher by about 0.3% on the day Thursday. TRV operates in the Insurance Brokers sector, among companies like Chubb Ltd (CB) which is up about 0.3% today, and American International Group Inc (AIG) trading up by about 0.2%. Below is a three month price history chart comparing the stock performance of TRV, versus CB and AIG. TRV is currently trading up about 0.5% midday Thursday.
More from Stocks
Dick's Sporting Goods Reportedly Again Mulls Halt to Firearms Sales
Dick's has been the most publicly prominent among the retailers about the subject of firearms sales, CNN reports.
Time to Shop? Jim Cramer Weighs in on Kohl's Earnings and the Market
Jim Cramer has some thoughts on Kohl's quarter and he explains why he's paying more attention to fantasy football.
Hain Celestial Drops After J.P. Morgan Turns Bearish
J.P. Morgan lowers its rating on the stock of the manufactured food company to underweight from neutral.
Endo Surges as Opioid Maker Reaches Settlement in Landmark Lawsuit
Endo's stock price surges after the company announces a settlement with Cuyahoga and Summit counties, removing the company from a potentially damaging trial in state court in October.